Trial intelligence / Profile preview

Periarticular Injections for Pain Control in TKA with Duramorph

NCT02570503Phase 4Terminated

Sponsor
Virginia Commonwealth University
Start
Oct 2015
Primary completion
Feb 2021
Modality
Recombinant Proteins and Enzymes, Orthosteric Ligands
Countries
1
01

Overview

A Phase 4 trial of ropivacaine, ketorolac, clonidine, epinephrine in osteoarthritis (OA), sponsored by Virginia Commonwealth University. Started Oct 2015; status: terminated.

02

Drugs

ropivacaineketorolacclonidineepinephrine
03

Conditions

osteoarthritis (OA)

Beyond the preview

Go deeper on NCT02570503.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02570503.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call